ASCO Genitourinary Cancers Symposium
Playback speed
10 seconds
ASCO GU 2022 on a Study EV-103 Cohort H: Antitumor Activity of Neoadjuvant Treatment With Enfortumab Vedotin Monotherapy in Cisplatin-Ineligible MIBC
By
ASCO Genitourinary Cancers Symposium
FEATURING
Daniel Petrylak
By
ASCO Genitourinary Cancers Symposium
FEATURING
Daniel Petrylak
158 views
March 8, 2022
Login to view comments.
Click here to Login
Videos